Pneumocystis jirovecii Pneumonia and HIV: A Practical Guide for ED Diagnosis and Management
How do you evaluate and manage the patient with Pneumocystis jirovecii pneumonia and HIV?
pneumonia
52 in 52 – #32: Hydrocortisone in Severe Community-Acquired Pneumonia
This week the ’52 in 52′ series covers hydrocortisone in patients with severe community-acquired pneumonia, or the CAPE-COD trial.
52 in 52 – #32: Hydrocortisone in Severe Community-Acquired Pneumonia Read More »
Journal Feed Weekly Wrap-Up
This Journal Feed Wrap-Up covers the updated ACEP clinical policy on pneumonia, TXA in TBI, and esmolol for septic shock.
Journal Feed Weekly Wrap-Up Read More »
Journal Feed Weekly Wrap-Up
This week Clay brings you three great articles on lactate, ultrasound for central line confirmation, and empiric MRSA coverage in pneumonia.
Journal Feed Weekly Wrap-Up Read More »
R.E.B.E.L. EM – Update in Community Acquired Pneumonia (CAP) Treatment: Macrolide Resistance
Most outpatients are treated with azithromycin (or another macrolide antibiotic) as this drug gives a simple treatment regimen (single drug, simple dosing, short course). However, the efficacy of this regimen has been questioned in recent years as resistance patterns shift.
Community-Acquired Pneumonia: ATS/IDSA Guidelines Update
The last community-acquired pneumonia guidelines from the ATS/IDSA were released in 2007. Ready for an update?
Community-Acquired Pneumonia: ATS/IDSA Guidelines Update Read More »
Choosing Wisely: Non-invasive ventilation in patients with acute respiratory failure from pneumonia
You have a patient with respiratory distress due to severe pneumonia. What should you do? Do you intubate immediately, place the patient on noninvasive positive pressure ventilation, or high flow nasal cannula? This post from Dr. Lentz and colleagues explores your options.
Pediatric Pneumonia
Let’s take another moment to ensure we are up to date with current recommendations for Pediatric Pneumonia.
Pediatric Pneumonia Read More »
Corticosteroids for Pneumonia: Ready for Primetime?
Corticosteroids attenuate local and systemic inflammatory responses. Are they ready for routine use in community acquired pneumonia? This post delves into the literature.
Corticosteroids for Pneumonia: Ready for Primetime? Read More »
emDocs Cases: ED Evaluation of Community-Acquired Pneumonia
Welcome to emDocs Cases! This is the first in a series examining core clinical cases. Today’s topic: the ED evaluation of community-acquired pneumonia including history, exam, imaging, and clinical scores.
emDocs Cases: ED Evaluation of Community-Acquired Pneumonia Read More »